Home/Filings/4/0001415889-25-021045
4//SEC Filing

Kolbeck Roland Wilhelm 4

Accession 0001415889-25-021045

CIK 0001557746other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:33 PM ET

Size

8.1 KB

Accession

0001415889-25-021045

Insider Transaction Report

Form 4
Period: 2025-08-01
Kolbeck Roland Wilhelm
Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2025-08-01+145,500145,500 total
    Common Stock (145,500 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-08-01+510,000510,000 total
    Exercise: $1.53Exp: 2035-07-31Common Stock (510,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
  • [F2]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
  • [F3]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Issuer

Aclaris Therapeutics, Inc.

CIK 0001557746

Entity typeother

Related Parties

1
  • filerCIK 0002076327

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:33 PM ET
Size
8.1 KB